Stem cells culled from bone marrow may prove beneficial in stroke recovery, scientists have learned. The researchers identified 46 studies that examined the use of mesenchymal stromal cells -- a type of multipotent adult stem cells mostly processed from bone marrow -- in animal models of stroke. They found MSCs to be significantly better than control therapy in 44 of the studies.